Back to search
FDAFDA · Food and drugs·Recall number D-0020-2023

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

Published November 2, 2022 · Recall initiated: September 30, 2022

Summary

FDA records drug Class II recall D-0020-2023, published November 2, 2022 and initiated September 30, 2022. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 11,520 units; Lot: Lot # CFN200020, EXP Nov. 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of specification for assay

What to do

Voluntary: Firm initiated · Letter

Get an email if FONDAPARINUX SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FONDAPARINUX SODIUM
Manufacturer
AuroMedics Pharma LLC
Distributor
Nationwide in the USA
Lot
Lot # CFN200020, EXP Nov. 2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe) recalled?

Yes. FDA published recall D-0020-2023 on November 2, 2022. Reported hazard: Subpotent Drug: Out of specification for assay

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FONDAPARINUX SODIUM.